Paper8913484
Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Moghazeh SL and 5 others. Antimicrob Agents Chemother, 1996. Cited by 96 papers, by iCite.
Cite this record
ConductScience Library. Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Papers, record 8913484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8913484
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antitubercular | Major topic |
| Mutation | Major topic |
| Mycobacterium tuberculosis | Major topic |
| Rifampin | Major topic |
| Rifamycins | Major topic |
| Drug Resistance, Microbial | |
| Microbial Sensitivity Tests |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI-37004 | NIAID NIH HHS | United States | R01AI037004 | PubMed and NIH | NIH RePORTER |
| DA09238 | NIDA NIH HHS | United States | R01DA009238 | PubMed and NIH | NIH RePORTER |
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8628338 | Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8628338 | PubMed |
| 2 | 8564140 | Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS. | Am J Respir Crit Care Med | 1996 | https://conductscience.org/library/papers/8564140 | PubMed |
| 3 | 8834869 | Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8834869 | PubMed |
| 4 | 8834891 | In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8834891 | PubMed |
| 5 | 8448815 | Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives. | Chem Pharm Bull (Tokyo) | 1993 | https://conductscience.org/library/papers/8448815 | PubMed |
| 6 | 8095569 | Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. | Lancet | 1993 | https://conductscience.org/library/papers/8095569 | PubMed |
| 7 | 8354898 | Tuberculosis symposium: emerging problems and promise. | J Infect Dis | 1993 | https://conductscience.org/library/papers/8354898 | PubMed |
| 8 | 8146134 | Evolution of drug-resistant tuberculosis: a tale of two species. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8146134 | PubMed |
| 9 | 8027320 | Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. | J Clin Microbiol | 1994 | https://conductscience.org/library/papers/8027320 | PubMed |
| 10 | 8031050 | The rpoB gene of Mycobacterium tuberculosis. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8031050 | PubMed |
| 11 | 7963745 | Is Mycobacterium tuberculosis 15,000 years old? | J Infect Dis | 1994 | https://conductscience.org/library/papers/7963745 | PubMed |
| 12 | 7991580 | Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7991580 | PubMed |
| 13 | 7840574 | Characterization of rifampin-resistance in pathogenic mycobacteria. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7840574 | PubMed |
| 14 | 7848059 | Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. | Arch Pathol Lab Med | 1995 | https://conductscience.org/library/papers/7848059 | PubMed |
| 15 | 7759399 | Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. | J Antimicrob Chemother | 1995 | https://conductscience.org/library/papers/7759399 | PubMed |
| 16 | 7663785 | Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. | Am J Respir Crit Care Med | 1995 | https://conductscience.org/library/papers/7663785 | PubMed |
| 17 | 8665467 | Antimicrobial agent resistance in mycobacteria: molecular genetic insights. | Clin Microbiol Rev | 1995 | https://conductscience.org/library/papers/8665467 | PubMed |
| 18 | 8849230 | Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8849230 | PubMed |
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37855280 | An Overview of Various Rifampicin Analogs against Mycobacterium tuberculosis and their Drug Interactions. | Med Chem | 2024 | https://conductscience.org/library/papers/37855280 | PubMed |
| 37237156 | Heterologous production of the D-cycloserine intermediate O-acetyl-L-serine in a human type II pulmonary cell model. | Sci Rep | 2023 | https://conductscience.org/library/papers/37237156 | PubMed |
| 35321759 | Establishment and evaluation of an overlap extension polymerase chain reaction technique for rapid and efficient detection of drug-resistance in Mycobacterium tuberculosis. | Infect Dis Poverty | 2022 | https://conductscience.org/library/papers/35321759 | PubMed |
| 32786275 | A Semisynthetic Kanglemycin Shows In Vivo Efficacy against High-Burden Rifampicin Resistant Pathogens. | ACS Infect Dis | 2020 | https://conductscience.org/library/papers/32786275 | PubMed |
| 32342856 | Inhibition of RNA Polymerase by Rifampicin and Rifamycin-Like Molecules. | EcoSal Plus | 2020 | https://conductscience.org/library/papers/32342856 | PubMed |
| 31408508 | Development and evaluation of novel bio-safe filter paper-based kits for sputum microscopy and transport to directly detect Mycobacterium tuberculosis and associated drug resistance. | PLoS One | 2019 | https://conductscience.org/library/papers/31408508 | PubMed |
| 29982641 | The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis. | J Antimicrob Chemother | 2018 | https://conductscience.org/library/papers/29982641 | PubMed |
| 29212699 | Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge. | J Clin Microbiol | 2018 | https://conductscience.org/library/papers/29212699 | PubMed |
| 28959248 | Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28959248 | PubMed |
| 27623312 | Cell-Based High-Throughput Screening Identifies Rifapentine as an Inhibitor of Amyloid and Biofilm Formation in Escherichia coli. | ACS Infect Dis | 2015 | https://conductscience.org/library/papers/27623312 | PubMed |
| 26792466 | Performance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in India. | Int J Tuberc Lung Dis | 2016 | https://conductscience.org/library/papers/26792466 | PubMed |
| 26528265 | Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin? | Front Microbiol | 2015 | https://conductscience.org/library/papers/26528265 | PubMed |
| 26459537 | Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations. | Int J Tuberc Lung Dis | 2015 | https://conductscience.org/library/papers/26459537 | PubMed |
| 26206684 | Detection of first-line anti-tuberculosis drug resistance mutations by allele-specific primer extension on a microsphere-based platform. | Ann Lab Med | 2015 | https://conductscience.org/library/papers/26206684 | PubMed |
| 25689534 | The future for early-stage tuberculosis drug discovery. | Future Microbiol | 2015 | https://conductscience.org/library/papers/25689534 | PubMed |
| 23966495 | Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devices. | J Clin Microbiol | 2013 | https://conductscience.org/library/papers/23966495 | PubMed |
| 23761144 | Rifampin drug resistance tests for tuberculosis: challenging the gold standard. | J Clin Microbiol | 2013 | https://conductscience.org/library/papers/23761144 | PubMed |
| 23679862 | X-ray crystal structures of the Escherichia coli RNA polymerase in complex with benzoxazinorifamycins. | J Med Chem | 2013 | https://conductscience.org/library/papers/23679862 | PubMed |
| 23593234 | A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis. | PLoS One | 2013 | https://conductscience.org/library/papers/23593234 | PubMed |
| 22763637 | Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. | Clin Microbiol Rev | 2012 | https://conductscience.org/library/papers/22763637 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8913484
GET https://conductscience.org/api/papers/v1/8913484/cited_by?page=2